The Marketing Director is responsible for the marketing/communications strategy and tactics for selected genetic programs in Germany, working closely with the Country Manager, the Sales Director and the international marketing team. The role is hands-on with a focus on strategic planning, forecasting, generating market insights, collaborating with International and Global teams, adapting the international strategy to the German market, cross-functional alignment with Medical, Sales, Market Access and Regulatory, and leading the execution of the local tactical plan.

Key Responsibilities

• Ensure flawless implementation of the German TTR plan in line with the international TTR plan and in cooperation with cross-functional stakeholders in the international region
• Own the annual promotional budget, conducting ROI assessments of tactical programs and ensures proper execution
• Hands-on support support in planning and organizing external events, as well as in creating training materials and concepts for HCPs, patients and nurses
• Responsible for the local strategic brand plan in close cross-functional collaboration
• Analyze the market, competition and stakeholders thereby leveraging all available tools of primary and secondary market research as well as in-field information provided by the commercial and medical teams and from KOLs.
• Create and defend concise and winning brand specific business plans and business cases to secure project funding within and beyond the annual investment plan process
• Build and lead cross-functional brand teams and ensure high level of engagement, alignment and customization of strategies and tactics that reflect key customer and market needs
• Represent Germany at international meetings, articulate German market and customer needs and asks and exert influence on the international brand strategy; leverage key learnings and opportunities from other markets to drive the German business
• Drive the development and implementation of an omnichannel communication plan (digital & print)
• Partner with legal, regulatory, and compliance stakeholders to ensure compliant development and execution of marketing initiatives
• Take ownership of the review process to ensure marketing materials are cleared for promotional use and secure final production
• Foster regular exchange with the field force to continuously support execution in the field
• Leverage best practices from within the commercial organization and continually foster learning from industry best practices
• Demonstrate excellence in project management and effectively managing multiple projects and priorities

Qualifications

• University degree in life sciences, business or a related field
• Outstanding analytical and strategic thinking combined with strong execution leadership
• Hands-on mentality and willingness to take responsibility for strategic and operational topics
• Extensive marketing experience in the pharmaceutical / biotech industry
• Knowledge and experience in rare diseases, cardiology or neurology strongly preferred
• Proven track record in pharmaceutical product and project management, and/or sales is required.
• Strong network/matrix stakeholder communications skills with both regional and in-country teams
• Strong business and financial acumen, coupled with relentless external customer, patient focus and negotiation skills
• Pronounced resilience, positive and solution focused thinking and acting
• Ability to engage and manage multiple stakeholders (internal/external) and effectively manage multiple projects simultaneously to achieve defined business goals
• Curious with learning agility, sense of urgency, ethics and responsibility
• Fluent in German and English
• Willingness to travel up to 25% of the time locally and internationally

About Alnylam

• Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
• Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
• At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.

About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.